The fountain of youth has been long been looked for by explorers. Researchers have been trying out ways to cheat death and extend the human lifespan. Many companies today have manufactured creams and pills which claim to make us look like we are not aging.
Dr. J. Craig Venter, an entrepreneur in biotech says that the main key lies in the sequencing of genomes and combining the data with other health metrics for better understanding the disease and aging. Once researchers understand it at a molecular level, they will be able to slow it down.
A new company owned by Dr. Venter, known as Human Longevity to focus on human DNA sequencing has been open, with the potential to map 40,000 genomes each year
This might sound like a heavy task, but it’s par for the course with Venter, who gained fame for his work on the first sequencing of the human genome. Human Longevity is starting with $70 million of venture funding, mostly from wealthy individuals.
The company hopes that by sequencing the genomes of people who are healthy, sick, young and old, the genome database may eventually be large enough to offer insight into the aging process. Another goal for decreasing the cost of sequencing individual genomes to about $1,000.
Last year, Google has also announced plans to fund research on extending human lifespans and has set up a company known as Calico to focus on ways to counteract the aging process.